Neither duration of anesthesia nor increased cumulative time with profound sevoflurane anesthesia was associated with increased risk for new malignant disease within five years after surgery in previously cancer-free patients, according to a study published in the Oct. 2011 issue of Anesthesia & Analgesia and reported by a Newswise.
Read the full report in Becker’s ASC Review on anesthesia’s effect on cancer risk.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
